NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Yesteryears rehashing again ... aye ex?

Can you provide some more information about systems that could potentially be used to make DCVax-L vs. waiting for EDEN to be ready.

I have listed some before. This paper lists several.

Several ... yes ... that can not make DCvax-L.

This report takes a close look at the Flaskworks Eden 2.0 system. NWBO's automated manufacturing platform developed specifically for producing dendritic cell vaccines like DCVax-L.

Some investors have raised reasonable questions: Could Northwest Biotherapeutics have used a system already on the market? Is Flaskworks Eden genuinely different, or just another version of what other companies already offer?

The goal here is to provide straightforward answers, based on the biology of dendritic cells, the engineering behind Eden, and the patent protections in place.

The report explains why manufacturing DCVax-L is particularly complex, especially when it comes to harvesting fragile, adherent dendritic cells without damaging them. It also outlines how Flaskworks Eden was built to handle these challenges, and why general-purpose systems like CliniMACS Prodigy or the Cocoon platform fall short.

Finally, it shows how Flaskworks Eden fits into Northwest’s broader manufacturing and regulatory plans, including its role at the Sawston facility and its path toward commercial production.

If you're invested in NWBO or evaluating its long-term prospects, understanding Flaskworks Eden is essential.

Stating several competitors can do that, is not true. They clearly CAN NOT!

PDF FILE
Flaskworks Eden 2.0 vs competitors